摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to field of pharmaceutics, namely, deals with compounds of formula, suitable for reduction of regulation of biological activity of melanocortin-5 receptor (MC5R). Such diseases and/or conditions include, but are not limited by, acne, seborrhoea, seborrheic dermatitis, cancer and inflammatory diseases.EFFECT: compounds of claimed invention can be applied for treatment of diseases and/or conditions, in which reducing regulation of MC5R is favourable.3 cl, 109 ex, 7 tbl |